Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Franck Lemiale"'
Autor:
Zachary K. Sagawa, Cristina Goman, Aude Frevol, Azra Blazevic, Janice Tennant, Bridget Fisher, Tracey Day, Stephen Jackson, Franck Lemiale, Leon Toussaint, Irene Kalisz, Joe Jiang, Lisa Ondrejcek, Raodoh Mohamath, Julie Vergara, Alan Lew, Anna Marie Beckmann, Corey Casper, Daniel F. Hoft, Christopher B. Fox
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Here the authors present results from a randomized, double-blinded Phase 1 clinical trial, testing a thermostable presentation of a clinical-stage adjuvanted subunit tuberculosis vaccine candidate. The vaccine candidate is safe and well tolerated, an
Externí odkaz:
https://doaj.org/article/0416e608bded4e49acce0289f6385372
Autor:
David Oyen, Jonathan L Torres, Phillip C Aoto, Yevel Flores-Garcia, Špela Binter, Tossapol Pholcharee, Sean Carroll, Sini Reponen, Rachael Wash, Qi Liang, Franck Lemiale, Emily Locke, Allan Bradley, C Richter King, Daniel Emerling, Paul Kellam, Fidel Zavala, Andrew B Ward, Ian A Wilson
Publikováno v:
PLoS Pathogens, Vol 16, Iss 3, p e1008373 (2020)
Lasting protection has long been a goal for malaria vaccines. The major surface antigen on Plasmodium falciparum sporozoites, the circumsporozoite protein (PfCSP), has been an attractive target for vaccine development and most protective antibodies s
Externí odkaz:
https://doaj.org/article/2b45fbb0cb2843a2913970e92e8e5bed
Autor:
Stephen W. Scally, Brandon McLeod, Alexandre Bosch, Kazutoyo Miura, Qi Liang, Sean Carroll, Sini Reponen, Ngan Nguyen, Eldar Giladi, Sebastian Rämisch, Vidadi Yusibov, Allan Bradley, Franck Lemiale, William R. Schief, Daniel Emerling, Paul Kellam, C. Richter King, Jean-Philippe Julien
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Plasmodium falciparum protein Pfs25 is a promising malaria transmission blocking vaccine antigen. Here, Scally et al. determine the crystal structure of Pfs25 and identify antigenic sites that are recognized by transmission-blocking antibodies elicit
Externí odkaz:
https://doaj.org/article/d1902f6099734fd8a2c75117c776ee4d
Autor:
Sidhartha Chaudhury, Jason A. Regules, Christian A. Darko, Sheetij Dutta, Anders Wallqvist, Norman C. Waters, Erik Jongert, Franck Lemiale, Elke S. Bergmann-Leitner
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract A recent study of the RTS,S malaria vaccine, which is based on the circumsporozoite protein (CSP), demonstrated an increase in efficacy from 50–60% to 80% when using a delayed fractional dose regimen, in which the standard 0–1–2 month
Externí odkaz:
https://doaj.org/article/da43572f2ab14d5da906e3ca77074fd9
Autor:
Špela Binter, Daniel Emerling, Yevel Flores-Garcia, Sini Reponen, Andrew B. Ward, C. Richter King, Rachael S. Wash, Sean M. Carroll, Paul Kellam, Phillip C. Aoto, Jonathan L. Torres, David Oyen, Fidel Zavala, Allan Bradley, Emily Locke, Franck Lemiale, Ian A. Wilson, Qi Liang, T. Pholcharee
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 16, Iss 3, p e1008373 (2020)
PLoS Pathogens, Vol 16, Iss 3, p e1008373 (2020)
Lasting protection has long been a goal for malaria vaccines. The major surface antigen on Plasmodium falciparum sporozoites, the circumsporozoite protein (PfCSP), has been an attractive target for vaccine development and most protective antibodies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c6d0fca680bc5b7a215b61e2d3b555
http://hdl.handle.net/10044/1/81513
http://hdl.handle.net/10044/1/81513
Autor:
Stephen W, Scally, Brandon, McLeod, Alexandre, Bosch, Kazutoyo, Miura, Qi, Liang, Sean, Carroll, Sini, Reponen, Ngan, Nguyen, Eldar, Giladi, Sebastian, Rämisch, Vidadi, Yusibov, Allan, Bradley, Franck, Lemiale, William R, Schief, Daniel, Emerling, Paul, Kellam, C Richter, King, Jean-Philippe, Julien
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Nature Communications
Nature Communications
The Plasmodium falciparum Pfs25 protein (Pfs25) is a leading malaria transmission-blocking vaccine antigen. Pfs25 vaccination is intended to elicit antibodies that inhibit parasite development when ingested by Anopheles mosquitoes during blood meals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::279abaecce8e54bb2d05b0b0f232f200
http://hdl.handle.net/10044/1/70143
http://hdl.handle.net/10044/1/70143
Autor:
Franck Lemiale, Elke S. Bergmann-Leitner, Sheetij Dutta, Norman C. Waters, Anders Wallqvist, Jason A. Regules, Erik Jongert, Christian A. Darko, Sidhartha Chaudhury
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
A recent study of the RTS,S malaria vaccine, which is based on the circumsporozoite protein (CSP), demonstrated an increase in efficacy from 50–60% to 80% when using a delayed fractional dose regimen, in which the standard 0–1–2 month immunizat
Autor:
Elke S. Bergmann-Leitner, Sheetij Dutta, Franck Lemiale, Jason A. Regules, Erik Jongert, Sidhartha Chaudhury, Christian F. Ockenhouse, Norman C. Waters, Anders Wallqvist
Publikováno v:
Malaria Journal
Background Recent vaccine studies have shown that the magnitude of an antibody response is often insufficient to explain efficacy, suggesting that characteristics regarding the quality of the antibody response, such as its fine specificity and functi
Publikováno v:
Vaccine. 28:3617-3624
Viral vectors are considered as one of the major means for the induction of strong immune responses against recombinant antigens by genetic immunization. Among these, lentiviral vectors are particularly attractive vehicles, as they can infect a wide
Publikováno v:
Vaccine. 28:1952-1961
Recently developed viral-vectored HIV vaccine candidates, despite achieving high levels transgene expression and inducing high magnitude immune responses to HIV, have faced limitations related to anti-vector immunity. In contrast, lentiviral vectors